The Goldman Sachs Group, Inc.
GS is being valued like a cyclical broker at 14.27x earnings even as earnings power, backlog, alternatives fundraising, and capital return all point to a structurally higher base of profitability.
GS is still being priced as if current earnings are close to a cyclical peak that should be discounted hard. The numbers do not support that view. FY2025 revenue reached $125.1B, up 10.9%, EPS jumped 59.0% to $51.95, and operating margin expanded to 34.4% from 14.5%. Then Q2 2026 added more evidence that the earnings base has moved higher: record revenue, record EPS of $20.98, and 23.5% ROE. At 14.27x earnings, the market is still not paying for a franchise that is executing well above its own recent history.
The first thing this case depends on is backlog conversion. That matters because management said investment banking backlog is at its highest level in 5 years, even after a strong quarter. This is not just a trading story. It points to advisory and underwriting revenue carrying into future quarters, and management explicitly said quarterly revenues for the remainder of 2026 should be broadly consistent with Q2. The second thing is alternatives and AWM durability. Fundraising hit $59B in Q2, full-year 2026 fundraising is now expected to exceed $125B, and AWM fees rose 20% YoY with 34 consecutive quarters of long-term net inflows. That mix supports a higher-quality earnings stream than investors used to assign GS.
The third thing is capital allocation. GS produced $5.6B of FCF, bought back $4.0B of stock, paid $1.6B in dividends, and raised the dividend to $5 per quarter. That matters at today's valuation because buybacks at 14.27x earnings are accretive in a way they are not for many financials trading closer to 18x. The stock is also -20.2% off its high and -3.9% below its 200-day, which creates a better entry than the same fundamentals would have offered a few months ago.
What keeps conviction from being absolute is balance-sheet intensity and dependence on market activity. Debt metrics are high, sponsor activity is still below historical averages, and management flagged SLR constraints. But those are known issues, and the operating evidence is stronger than the skepticism embedded in the multiple. The market is still underestimating how much cleaner, more fee-rich, and more capital-disciplined GS has become.
Backlog converts cleanly, fundraising beats the $125B target by a wide margin, and AI-led financing and advisory demand extend the current revenue run-rate into 2027.
Record Q2 conditions fade somewhat but remain strong enough for above-cycle earnings, supporting the engine target and a valuation closer to peers.
Backlog conversion slips, sponsor activity stays muted, and markets normalize enough that investors value GS closer to the low end of its recent range.
Quant call aligns with analyst consensus (Buy: 4 buy / 7 hold / 1 sell).
Go for a business that any idiot can run — because sooner or later, any idiot probably will.
Forward earnings power is higher than the trailing multiple implies. On FY2025 EPS of $51.95, the stock trades at 14.27x, but current run-rate profitability is being shaped by a much stronger 2026 setup: $20.98 of Q2 EPS, a 23.5% ROE, a 5-year high banking backlog, and management guidance that quarterly revenues for the remainder of 2026 should be broadly consistent with Q2. The moat looks stronger now than it did 3 to 5 years ago because the firm has exited weaker consumer economics, deepened its financing and equities franchise, and expanded durable AWM fee streams with 34 straight quarters of inflows. AI is more tailwind than threat here, not because GS sells AI, but because the AI infrastructure build-out drives financing, underwriting, advisory, and sponsor monetization activity across debt, equity, and private markets; the main secular offset is tighter regulation on balance-sheet usage, especially SLR-related constraints.
- Valuation remains undemanding at 14.27x FY2025 EPS of $51.95, versus 17.3x for peers.
- Operating performance inflected hard in FY2025, with revenue $125.1B, up 10.9%, and operating margin 34.4% versus 14.5% the prior year.
- Forward setup strengthened in Q2 2026: record EPS $20.98, ROE 23.5%, backlog at a 5-year high, and alternatives fundraising now guided to above $125B for FY26.
- GS has delivered 8 consecutive EPS beats, including +45.0% in July 2026, +19.7% in January 2026, and +48.8% in January 2025, which supports confidence that management is still under-promising relative to actual earnings power.
- The business mix is improving. AWM fees were up 20% YoY in Q2 2026, long-term net inflows have reached 34 consecutive quarters, and fundraising hit $59B in Q2 alone, reducing reliance on any single trading quarter.
- Capital return is meaningful and immediate: GS bought back $4.0B of stock in Q2, paid $1.6B of dividends, and raised the quarterly dividend to $5 per share, signaling confidence in capital generation.
- The stock setup is favorable after a reset. Shares are -20.2% from the 52-week high and -3.9% below the 200-day average even though business conditions are stronger now than when the stock traded materially higher.
- Balance-sheet intensity is real. Debt/equity is 6.04, debt/EBITDA is 30.87, and the current ratio is 0.83, which is normal for a wholesale financial institution but still leaves less room for error if market activity cools.
- Some growth still depends on market-sensitive businesses. Management said sponsor activity remains subdued versus historical averages, so the backlog must convert to fees for the current optimism to hold.
- Q2 EBITDA margin was 31.3%, down 970 bps sequentially from Q1, showing that even record revenue does not eliminate quarter-to-quarter volatility in mix and compensation.
- Management explicitly warned the AI build-out cycle will not be a straight line, and also noted SLR and other balance-sheet constraints could limit financing growth if demand stays elevated.
| Metric | Value | Context |
|---|---|---|
| Current price | $921.46 | Used against engine base target of $1108.27 |
| Price target | $1108.27 | 20.3% upside, High confidence, earnings_growth_blend |
| FY2025 revenue | $125.1B | 10.9% YoY growth |
| FY2025 EPS | $51.95 | 59.0% YoY growth |
| Operating margin | 34.4% | Versus 14.5% in prior FY |
| Net margin | 26.7% | High profitability for the cycle |
| P/E | 14.27x | Below peer average 17.3x |
| Q2 2026 EPS | $20.98 | Versus $14.47 estimate, +45.0% beat |
| Q2 2026 EBITDA | $12.03B | On $38.43B revenue, margin 31.3% |
| Capital return | $4.0B buybacks, $1.6B dividends | Dividend raised to $5/share quarterly |
| Balance sheet | Debt/Equity 6.04, Debt/EBITDA 30.87, Current ratio 0.83 | Normal for the business model, but still a key watchpoint |
| 52-week position | -20.2% vs high | Price $921.46 versus 52-week range $740.01-$1153.99 |
The biggest risk is a sharp slowdown in capital-markets conversion from today's backlog, because the stock is underwriting stronger fee realization after a record Q2 and a 5-year high backlog.
Q3 earnings on October 13, 2026, where investors need to see backlog conversion, continued AWM fee momentum, and revenue tracking management's comment that the rest of 2026 should be broadly consistent with Q2.
Ownership is institutional and concentrated, with the top 3 holders at 68.9%, which usually dampens the odds of a disorderly unwind but can amplify moves around earnings when positioning gets crowded. Short interest is modest at 2.34% of shares, or 6.98M shares and 3.3 days to cover, so the thesis does not depend on a squeeze. Options positioning is less helpful near term, with a negative gamma regime and zero-gamma at $954.7, above spot, which can keep trading choppy until earnings reset expectations.
Q2 2026 strength was driven by GBM, with record equities revenue, broad-based FICC strength, and a banking backlog at a 5-year high.
AUM/AUS was $3.1T on the 2024 Q3 call, AWM fees rose 20% YoY in Q2 2026, and long-term inflows reached 34 consecutive quarters.
Management expects quarterly revenue for the remainder of 2026 to be broadly consistent with $221M, while the strategy has shifted away from lower-return consumer exposure.
Management is increasing capital deployment into Asia equities, deals book, and financing, pointing to stronger demand outside the US as well.
Goldman posted record Q2 results and pointed to continued strong client activity with backlog at a 5-year high.
Execution has been strong and credibility has improved materially since the 2024 Q3 call. Back then management pointed to a better forward setup, said backlog had risen, expected 2024 fundraising to exceed $60B, targeted a tax rate of about 22%, and was still working through the GM card transfer and other consumer exits that cut Q3 2024 EPS by $0.62. Since then, the company has delivered 8 straight EPS beats, lifted FY2025 EPS to $51.95, expanded operating margin to 34.4% from 14.5%, and shifted the narrative from cleanup to offense, with Q2 2026 producing record net revenues of $20.3B, $59B of alternatives fundraising in one quarter, and a FY26 tax guide of about 20%. The strategic direction has changed in an important way: consumer drag has faded, AWM durability strengthened from 27 to 34 consecutive quarters of net inflows, and management is now leaning into financing, private markets, and AI-related capital formation. On the evidence, Solomon and Coleman have earned credibility.
We delivered record results for the second quarter and year to date.
Given our progress and what we see in our pipelines, we expect this flywheel of activity to continue.
Given the strength we've seen year to date, we now expect full-year fundraising to exceed $125 billion.
We expect quarterly revenues for the remainder of the year to be broadly consistent with the second quarter.
Our expectation, Ebrahim, is certainly that's going to continue. All the indicators we have is that we are in the relative early innings of a very, very significant, when you're talking about the AI build-out cycle, of an AI build-out cycle.
GS still has one of the deepest institutional client networks in global finance, and that matters most in advisory, underwriting, financing, and trading when market activity rebounds. The moat is not just brand, it is the combination of issuer relationships, risk intermediation capability, private-market distribution, and balance-sheet access that few firms can replicate at scale. Durability looks better today because the business mix has moved toward higher-quality AWM fees and away from subscale consumer bets that diluted returns.
Capital allocation has been disciplined recently. GS generated $5.6B of FCF, spent just $0.5B on capex, repurchased $4.0B of stock, and paid $1.6B in dividends, while also raising the quarterly dividend to $5 per share. That mix suggests management sees the best return in shrinking share count and supporting per-share earnings rather than stretching for large acquisitions.
GS rates a BUY at High conviction. The stock offers a rare combination of strong current execution, visible near-term catalysts, and a valuation that still sits below peers at 14.27x earnings. The market has punished the shares from the high even as the business outlook improved, which is the kind of mismatch worth buying. A downgrade would require evidence that the 5-year high backlog is not converting, or that capital and regulatory constraints are capping earnings despite strong demand. Until then, the path of least resistance is higher toward $1108.27.
≣ Full research note tap to expand
Executive Summary
BUY, High conviction. Rated BUY, High conviction. GS sits 20.2% below its 52-week high after a sharp pullback, yet the company just posted record Q2 EPS of $20.98, a 23.5% ROE, and said investment banking backlog is at a 5-year high with FY26 fundraising now expected to exceed $125B. At 14.27x FY2025 EPS and below the 17.3x peer average, the stock still does not reflect the forward earnings power of a business that has beaten estimates in 8 straight quarters and is returning capital aggressively.
Investment Thesis
GS is still being priced as if current earnings are close to a cyclical peak that should be discounted hard. The numbers do not support that view. FY2025 revenue reached $125.1B, up 10.9%, EPS jumped 59.0% to $51.95, and operating margin expanded to 34.4% from 14.5%. Then Q2 2026 added more evidence that the earnings base has moved higher: record revenue, record EPS of $20.98, and 23.5% ROE. At 14.27x earnings, the market is still not paying for a franchise that is executing well above its own recent history.
The first thing this case depends on is backlog conversion. That matters because management said investment banking backlog is at its highest level in 5 years, even after a strong quarter. This is not just a trading story. It points to advisory and underwriting revenue carrying into future quarters, and management explicitly said quarterly revenues for the remainder of 2026 should be broadly consistent with Q2. The second thing is alternatives and AWM durability. Fundraising hit $59B in Q2, full-year 2026 fundraising is now expected to exceed $125B, and AWM fees rose 20% YoY with 34 consecutive quarters of long-term net inflows. That mix supports a higher-quality earnings stream than investors used to assign GS.
The third thing is capital allocation. GS produced $5.6B of FCF, bought back $4.0B of stock, paid $1.6B in dividends, and raised the dividend to $5 per quarter. That matters at today's valuation because buybacks at 14.27x earnings are accretive in a way they are not for many financials trading closer to 18x. The stock is also -20.2% off its high and -3.9% below its 200-day, which creates a better entry than the same fundamentals would have offered a few months ago.
What keeps conviction from being absolute is balance-sheet intensity and dependence on market activity. Debt metrics are high, sponsor activity is still below historical averages, and management flagged SLR constraints. But those are known issues, and the operating evidence is stronger than the skepticism embedded in the multiple. The market is still underestimating how much cleaner, more fee-rich, and more capital-disciplined GS has become.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $921.46 | Used against engine base target of $1108.27 |
| Price target | $1108.27 | 20.3% upside, High confidence, earnings_growth_blend |
| FY2025 revenue | $125.1B | 10.9% YoY growth |
| FY2025 EPS | $51.95 | 59.0% YoY growth |
| Operating margin | 34.4% | Versus 14.5% in prior FY |
| Net margin | 26.7% | High profitability for the cycle |
| P/E | 14.27x | Below peer average 17.3x |
| Q2 2026 EPS | $20.98 | Versus $14.47 estimate, +45.0% beat |
| Q2 2026 EBITDA | $12.03B | On $38.43B revenue, margin 31.3% |
| Capital return | $4.0B buybacks, $1.6B dividends | Dividend raised to $5/share quarterly |
| Balance sheet | Debt/Equity 6.04, Debt/EBITDA 30.87, Current ratio 0.83 | Normal for the business model, but still a key watchpoint |
| 52-week position | -20.2% vs high | Price $921.46 versus 52-week range $740.01-$1153.99 |
Financial Strength
GS is financially sound enough for a BUY, but the strength comes from earnings power and capital generation, not from a conservative-looking balance sheet. The raw leverage metrics, 6.04x debt/equity and 30.87x debt/EBITDA, are elevated and should be respected, yet that is partly the nature of a large market-making and financing platform rather than a distress signal on its own. More important is that profitability has inflected sharply, with FY2025 operating margin at 34.4% and net margin at 26.7%, while Q2 2026 still produced $12.03B of EBITDA and enough excess capital for $4.0B of buybacks plus a higher dividend. The read is that the balance sheet is a source of earnings capacity, but also the main constraint if regulation tightens or financing demand outruns capital flexibility.
Competitive Position
GS still has one of the deepest institutional client networks in global finance, and that matters most in advisory, underwriting, financing, and trading when market activity rebounds. The moat is not just brand, it is the combination of issuer relationships, risk intermediation capability, private-market distribution, and balance-sheet access that few firms can replicate at scale. Durability looks better today because the business mix has moved toward higher-quality AWM fees and away from subscale consumer bets that diluted returns.
Management & Guidance
Current guidance is notably stronger than it was a year earlier. Management now expects alternatives fundraising to exceed $125B in FY26, an effective tax rate of about 20%, materially higher incentive fees in the second half, and quarterly revenues for the rest of 2026 to be broadly consistent with Q2. That last point is especially important because it implies confidence that client activity and backlog conversion can offset normal quarter-to-quarter market noise. Credibility is high given the 8-quarter beat streak and the fact that earlier promises around backlog improvement, fundraising durability, and reducing consumer drag have largely been borne out in the numbers.
Segment Analysis
- Global Banking & Markets (Primary earnings engine, exact FY2025 segment split not provided): Q2 2026 strength was driven by GBM, with record equities revenue, broad-based FICC strength, and a banking backlog at a 5-year high.
- Asset & Wealth Management (Meaningful durable-fee contributor, exact FY2025 segment split not provided): AUM/AUS was $3.1T on the 2024 Q3 call, AWM fees rose 20% YoY in Q2 2026, and long-term inflows reached 34 consecutive quarters.
- Platform Solutions and legacy consumer runoff (Small and declining strategic importance): Management expects quarterly revenue for the remainder of 2026 to be broadly consistent with $221M, while the strategy has shifted away from lower-return consumer exposure.
- Geography (Geographic revenue split not provided): Management is increasing capital deployment into Asia equities, deals book, and financing, pointing to stronger demand outside the US as well.
Capital Allocation
Capital allocation has been disciplined recently. GS generated $5.6B of FCF, spent just $0.5B on capex, repurchased $4.0B of stock, and paid $1.6B in dividends, while also raising the quarterly dividend to $5 per share. That mix suggests management sees the best return in shrinking share count and supporting per-share earnings rather than stretching for large acquisitions.
Management Execution & Track Record
Execution has been strong and credibility has improved materially since the 2024 Q3 call. Back then management pointed to a better forward setup, said backlog had risen, expected 2024 fundraising to exceed $60B, targeted a tax rate of about 22%, and was still working through the GM card transfer and other consumer exits that cut Q3 2024 EPS by $0.62. Since then, the company has delivered 8 straight EPS beats, lifted FY2025 EPS to $51.95, expanded operating margin to 34.4% from 14.5%, and shifted the narrative from cleanup to offense, with Q2 2026 producing record net revenues of $20.3B, $59B of alternatives fundraising in one quarter, and a FY26 tax guide of about 20%. The strategic direction has changed in an important way: consumer drag has faded, AWM durability strengthened from 27 to 34 consecutive quarters of net inflows, and management is now leaning into financing, private markets, and AI-related capital formation. On the evidence, Solomon and Coleman have earned credibility.
Positioning & Flows
Ownership is institutional and concentrated, with the top 3 holders at 68.9%, which usually dampens the odds of a disorderly unwind but can amplify moves around earnings when positioning gets crowded. Short interest is modest at 2.34% of shares, or 6.98M shares and 3.3 days to cover, so the thesis does not depend on a squeeze. Options positioning is less helpful near term, with a negative gamma regime and zero-gamma at $954.7, above spot, which can keep trading choppy until earnings reset expectations.
Bull Case
- GS has delivered 8 consecutive EPS beats, including +45.0% in July 2026, +19.7% in January 2026, and +48.8% in January 2025, which supports confidence that management is still under-promising relative to actual earnings power.
- The business mix is improving. AWM fees were up 20% YoY in Q2 2026, long-term net inflows have reached 34 consecutive quarters, and fundraising hit $59B in Q2 alone, reducing reliance on any single trading quarter.
- Capital return is meaningful and immediate: GS bought back $4.0B of stock in Q2, paid $1.6B of dividends, and raised the quarterly dividend to $5 per share, signaling confidence in capital generation.
- The stock setup is favorable after a reset. Shares are -20.2% from the 52-week high and -3.9% below the 200-day average even though business conditions are stronger now than when the stock traded materially higher.
Bear Case
- Balance-sheet intensity is real. Debt/equity is 6.04, debt/EBITDA is 30.87, and the current ratio is 0.83, which is normal for a wholesale financial institution but still leaves less room for error if market activity cools.
- Some growth still depends on market-sensitive businesses. Management said sponsor activity remains subdued versus historical averages, so the backlog must convert to fees for the current optimism to hold.
- Q2 EBITDA margin was 31.3%, down 970 bps sequentially from Q1, showing that even record revenue does not eliminate quarter-to-quarter volatility in mix and compensation.
- Management explicitly warned the AI build-out cycle will not be a straight line, and also noted SLR and other balance-sheet constraints could limit financing growth if demand stays elevated.
Valuation & Price Target
Engine price target $1108.27 (+20.3% vs current), High confidence.
- P/E Multiple: $1144.66 (28% weight)
- PEG (growth-adjusted): $1073.21 (20% weight)
- P/S Multiple: $1251.9 (20% weight)
- Quality-adjusted: $1122.56 (20% weight)
- DCF: $800.51 (11% weight)
This rating aligns with the quant baseline BUY (High conviction) and the $1108.27 price target. The key reason not to fight the model is simple: GS trades at only 14.27x FY2025 EPS despite 10.9% revenue growth, 59.0% EPS growth, 34.4% operating margin, a 23.5% Q2 ROE, and a forward pipeline that management says is the strongest in 5 years. The sell-side consensus is also Buy, but that is low-signal context only; the case stands on GS's own numbers, especially the beat streak, backlog, fundraising guidance, and large buybacks after a 20.2% pullback from the high.
Risk Assessment
Risk score 38/100 (Low). The biggest risk is a sharp slowdown in capital-markets conversion from today's backlog, because the stock is underwriting stronger fee realization after a record Q2 and a 5-year high backlog.
The Bottom Line
GS rates a BUY at High conviction. The stock offers a rare combination of strong current execution, visible near-term catalysts, and a valuation that still sits below peers at 14.27x earnings. The market has punished the shares from the high even as the business outlook improved, which is the kind of mismatch worth buying. A downgrade would require evidence that the 5-year high backlog is not converting, or that capital and regulatory constraints are capping earnings despite strong demand. Until then, the path of least resistance is higher toward $1108.27.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr